See also this year's filing and all EDGAR filings for this company.
PDF Report 0001631650_2018_Aimmune_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001631650')"} |
Graph
Absolute values for 0001631650, Aimmune Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 189,111,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 17,205,000 |
| 3 | remainder_Assets | 618,000 |
| 4 | LiabilitiesCurrent | 26,599,000 |
| 5 | LiabilitiesNoncurrent | 2,530,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 43,949,000 |
| 9 | ResearchAndDevelopmentExpense | 89,325,000 |
| 10 | remainder_Expenses | 56,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,005,000 |
| 13 | remainder_ComprehensiveNetIncome | -81,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 206,934,000 |
| 1 | Liabilities | 29,129,000 |
| 2 | Expenses | 133,330,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 177,805,000 |
| 5 | NetIncome | -131,325,000 |
| 6 | ComprehensiveNetIncome | -131,365,500 |
| 7 | BaseVar | 185,739,500 |
| 8 | EconomicCapitalRatio | 1.48 |
Edgar->Model Mapping
Feature Distribution
Change over Time
